Holen Sie sich die Stockscreener-App
14.80
0.00%
0.00
Handel nachbörslich:
14.78
-0.02
-0.14%
89 Bio Inc Aktie (ETNB) Neueste Nachrichten
Investors Purchase High Volume of Put Options on 89BIO (NASDAQ:ETNB) - Defense World
Roche commences tender offer for all shares of 89bio, Inc. - GlobeNewswire
$20.50 Per Share Deal: Roche Makes Move to Acquire 89bio in Major Biotech Tender Offer - Stock Titan
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash - Yahoo Finance
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal - MSN
Kala Bio Stock Just Plunged 89% Today – Here’s What Happened - Stocktwits
Why 89bio Inc. stock is rated strong buy2025 Biggest Moves & Verified Entry Point Detection - newser.com
Technical analysis overview for 89bio Inc. stock2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Will 89bio Inc. stock split attract more investorsWeekly Trend Recap & Daily Profit Maximizing Trade Tips - newser.com
Is 89bio Inc. stock attractive for retirement portfoliosWeekly Stock Report & Momentum Based Trading Ideas - newser.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders - GlobeNewswire Inc.
Backtesting results for 89bio Inc. trading strategiesQuarterly Trade Review & Short-Term High Return Strategies - newser.com
How 89bio Inc. stock reacts to global recession fearsBear Alert & Community Consensus Picks - newser.com
Measuring 89bio Inc.’s beta against major indicesEarnings Overview Report & Daily Profit Maximizing Trade Tips - newser.com
89bio, Inc. Hits New 52-Week High of $15.06, Up 76.62% - Markets Mojo
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 89bio, Inc. (NASDAQ: ETNB) - PR Newswire
How to integrate 89bio Inc. into portfolio analysis toolsJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
Applying chart zones and confluence areas to 89bio Inc.Forecast Cut & Free Technical Pattern Based Buy Signals - newser.com
Real time breakdown of 89bio Inc. stock performance2025 Historical Comparison & Entry Point Strategy Guides - newser.com
Roche To Buy 89bio For Up To $3.5 Billion - Pulse 2.0
89Bio (ETNB) Soars 86 Percent to Historic High on $3.5-Billion Roche Merger - MSN
Will 89bio Inc. continue its uptrendPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Published on: 2025-09-19 14:02:20 - newser.com
Has 89bio Inc. found a price floor2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
89bio Stock Price, Quotes and Forecasts | NASDAQ:ETNB - Benzinga
89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc.ETNB - Business Wire
Dow Update: Is 89bio Inc trading at a discountWeekly Trade Analysis & Reliable Price Breakout Alerts - خودرو بانک
Roche to Buy 89bio for Up to $3.5 Billion in Obesity Push - MSN
89bio Inc. stock chart pattern explainedMarket Growth Summary & AI Forecast for Swing Trade Picks - newser.com
Roche Makes Major MASH Bid, Offering $2.4bn For 89bio - insights.citeline.com
Roche’s 89bio Buyout: Building A Combo-Ready Metabolic Franchise Beyond GLP-1 Wars (RHHBY) - Seeking Alpha
Roche Scoops Up 89bio In A $2.4 Billion Deal - Finimize
89bio: Pegozafermin MASH Drug Advancement Nets Roche Acquisition (NASDAQ:ETNB) - Seeking Alpha
Roche To Buy 89bio in $3.5 Billion Deal - USA Herald
Roche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic Push - Benzinga
Roche Expands Cardiometabolic Pipeline With 89bio Acquisition (OTCMKTS:RHHBY) - Seeking Alpha
RHHBY to Acquire 89bio for $3.5B, Add Late-Stage MASH Drug to Pipeline - Yahoo Finance
MASH dash speeds up as Roche acquires 89bio for up to $3.5B - BioWorld MedTech
Roche deal to buy 89bio boosts MASH space (ETNB:NASDAQ) - Seeking Alpha
Is ETNB Stock a Bargain or a Risk? - StocksToTrade
Roche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 Billion - The Wall Street Journal
89bio Stock Surge: Time to Invest? - timothysykes.com
Roche to acquire liver drug developer 89bio for up to $3.5 billion - Reuters
Why Did 89bio Stock Nearly Double In Value Today? - Stocktwits
ETNB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 89bio, Inc. Is Fair to Shareholders - Business Wire
Roche to Buy Biopharmceutical Firm 89bio in $3.5 Billion Deal - Bloomberg.com
Roche enters into a definitive merger agreement to acquire - GlobeNewswire
Roche Holding AG agreed to acquire 89bio, Inc. for $2.2 billion in a tender offer transaction. - MarketScreener
Shareholder Alert: The Ademi Firm Investigates Whether 89bio, Inc. is Obtaining a Fair Price for its Public Shareholders - Business Wire
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):